Skip to content
Catalyst

Emblica officinalisFinding

Emblica officinalis decreases LDL cholesterol

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“Treatment with P. emblica 250 mg, P. emblica 500 mg, and atorvastatin siginificantly reduced the levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides, and increased high-density lipoprotein cholesterol levels compared with baseline and placebo.”
Quoted verbatim from Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.
This finding among the 103 findings on its endpoint

Emblica officinalis

LDL cholesterol

lowers

Who
Adults aged 30 to 68 with type 2 diabetes (fasting glucose 110-126 mg/dL, HbA1c 7-9%) and endothelial dysfunction, all on stable metformin 1,500-3,000 mg in every arm; 20 per arm; both amla dose arms reported together; an atorvastatin arm also ran against the same placebo
Dose studied
250 mg or 500 mg twice daily for 12 weeks (two dose arms)

Moderate evidencePMID 23935377 · 2013

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Diabetes, metabolic syndrome and obesity
What else it reported5 findings · 0 compounds · 5 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7060WQQRAQTE9X43151Z7RS